Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 337,277 | 286,630 | 276,371 | 248,997 | 197,668 |
| Cost of Goods | 86,845 | 87,915 | 110,104 | 71,837 | 77,440 |
| Gross Profit | 250,432 | 198,715 | 166,267 | 177,160 | 120,228 |
| Operating Expenses | 235,362 | 224,567 | 198,395 | 168,542 | 125,833 |
| Operating Income | 15,915 | -24,937 | -32,024 | 9,455 | -5,165 |
| Interest Expense | 21,949 | 18,047 | 7,061 | 7,725 | 8,278 |
| Other Income | 5,609 | 513 | 1,241 | 390 | -100 |
| Pre-tax Income | -425 | -42,471 | -37,844 | 2,120 | -13,543 |
| Income Tax | 46 | 140 | 105 | 264 | 173 |
| Net Income Continuous | -471 | -42,611 | -37,949 | 1,856 | -13,716 |
| Net Income | $-471 | $-42,611 | $-37,949 | $1,856 | $-13,716 |
| EPS Basic Total Ops | -0.01 | -1.07 | -1.02 | 0.05 | -0.39 |
| EPS Basic Continuous Ops | -0.01 | -1.07 | -1.02 | 0.05 | -0.39 |
| EPS Diluted Total Ops | -0.01 | -1.07 | -1.02 | 0.04 | -0.39 |
| EPS Diluted Continuous Ops | -0.01 | -1.07 | -1.02 | 0.04 | -0.39 |
| EPS Diluted Before Non-Recurring Items | 0.29 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $43,469 | $567 | $-14,538 | $25,513 | $9,496 |